Search and Browse
Download
Enter Data
| Reaction Details | |||
|---|---|---|---|
 | Report a problem with these data | ||
| Target | Muscarinic acetylcholine receptor M3 | ||
| Ligand | BDBM50522821 | ||
| Substrate/Competitor | n/a | ||
| Meas. Tech. | ChEMBL_1888526 (CHEMBL4390203) | ||
| Ki | 1.7±n/a nM | ||
| Citation |  Yamashita, Y; Tanaka, KI; Yamakawa, N; Asano, T; Kanda, Y; Takafuji, A; Kawahara, M; Takenaga, M; Fukunishi, Y; Mizushima, T Chemical modification-mediated optimisation of bronchodilatory activity of mepenzolate, a muscarinic receptor antagonist with anti-inflammatory activity. Bioorg Med Chem27:3339-3346 (2019) [PubMed] Article | ||
| More Info.: | Get all data from this article, Assay Method | ||
| Muscarinic acetylcholine receptor M3 | |||
| Name: | Muscarinic acetylcholine receptor M3 | ||
| Synonyms: | ACM3_HUMAN | CHRM3 | Cholinergic, muscarinic M3 | Muscarinic Receptors M3 | Muscarinic receptor M3 | RecName: Full=Muscarinic acetylcholine receptor M3 | ||
| Type: | Enzyme | ||
| Mol. Mass.: | 66151.03 | ||
| Organism: | Homo sapiens (Human) | ||
| Description: | P20309 | ||
| Residue: | 590 | ||
| Sequence: |
| ||
| BDBM50522821 | |||
| n/a | |||
| Name | BDBM50522821 | ||
| Synonyms: | CHEMBL4450188 | ||
| Type | Small organic molecule | ||
| Emp. Form. | C30H33BrFNO3 | ||
| Mol. Mass. | 554.49 | ||
| SMILES | [Br-].OC(C(=O)OC1C[N+]2(CCCc3ccc(F)cc3)CCC1CC2)(c1ccccc1)c1ccccc1 |(13.36,-19.18,;4.01,-20.28,;5.35,-21.05,;6.68,-21.82,;6.69,-23.36,;8.01,-21.04,;9.35,-21.81,;10.68,-21.03,;12,-21.81,;13.34,-21.04,;14.67,-21.82,;16,-21.05,;17.34,-21.82,;17.33,-23.36,;18.66,-24.13,;20,-23.36,;21.33,-24.14,;20,-21.82,;18.66,-21.05,;12.01,-23.35,;10.68,-24.11,;9.35,-23.35,;10.84,-23.15,;10.49,-22.1,;5.34,-19.51,;6.67,-18.74,;6.67,-17.2,;5.33,-16.43,;4,-17.22,;4.01,-18.75,;4.01,-21.83,;2.68,-21.05,;1.35,-21.83,;1.35,-23.37,;2.7,-24.13,;4.02,-23.36,)| | ||
| Structure | 
| ||